Amber M Leaver1, Randall Espinoza2, Tara Pirnia1, Shantanu H Joshi1, Roger P Woods3, Katherine L Narr3. 1. Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, University of California Los Angeles, 635 Charles E Young Drive S #225, Los Angeles, CA, 90095. 2. Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, 200 UCLA Medical Plaza #265, Los Angeles, CA, 90095. 3. Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, University of California Los Angeles, 635 Charles E Young Drive S #225, Los Angeles, CA, 90095; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, 200 UCLA Medical Plaza #265, Los Angeles, CA, 90095.
Abstract
INTRODUCTION: One of the most effective interventions for intractable major depressive episodes is electroconvulsive therapy (ECT). Because ECT is also relatively fast-acting, longitudinal study of its neurobiological effects offers critical insight into the mechanisms underlying depression and antidepressant response. Here we assessed modulation of intrinsic brain activity in corticolimbic networks associated with ECT and clinical response. METHODS: We measured resting-state functional connectivity (RSFC) in patients with treatment-resistant depression (n=30), using functional magnetic resonance imaging (fMRI) acquired before and after completing a treatment series with right-unilateral ECT. Using independent component analysis, we assessed changes in RSFC with 1) symptom improvement and 2) ECT regardless of treatment outcome in patients, with reference to healthy controls (n=33, also scanned twice). RESULTS: After ECT, consistent changes in RSFC within targeted depression-relevant functional networks were observed in the dorsal anterior cingulate (ACC), mediodorsal thalamus (mdTh), hippocampus, and right anterior temporal, medial parietal, and posterior cingulate cortex in all patients. In a separate analysis, changes in depressive symptoms were associated with RSFC changes in the dorsal ACC, mdTh, putamen, medial prefrontal, and lateral parietal cortex. RSFC of these regions did not change in healthy controls. CONCLUSIONS: Neuroplasticity underlying clinical change was in part separable from changes associated with the effects of ECT observed in all patients. However, both ECT and clinical change were associated with RSFC modulation in dorsal ACC, mdTh and hippocampus, which may indicate that these regions underlie the mechanisms of clinical outcome in ECT and may be effective targets for future neurostimulation therapies.
INTRODUCTION: One of the most effective interventions for intractable major depressive episodes is electroconvulsive therapy (ECT). Because ECT is also relatively fast-acting, longitudinal study of its neurobiological effects offers critical insight into the mechanisms underlying depression and antidepressant response. Here we assessed modulation of intrinsic brain activity in corticolimbic networks associated with ECT and clinical response. METHODS: We measured resting-state functional connectivity (RSFC) in patients with treatment-resistant depression (n=30), using functional magnetic resonance imaging (fMRI) acquired before and after completing a treatment series with right-unilateral ECT. Using independent component analysis, we assessed changes in RSFC with 1) symptom improvement and 2) ECT regardless of treatment outcome in patients, with reference to healthy controls (n=33, also scanned twice). RESULTS: After ECT, consistent changes in RSFC within targeted depression-relevant functional networks were observed in the dorsal anterior cingulate (ACC), mediodorsal thalamus (mdTh), hippocampus, and right anterior temporal, medial parietal, and posterior cingulate cortex in all patients. In a separate analysis, changes in depressive symptoms were associated with RSFC changes in the dorsal ACC, mdTh, putamen, medial prefrontal, and lateral parietal cortex. RSFC of these regions did not change in healthy controls. CONCLUSIONS: Neuroplasticity underlying clinical change was in part separable from changes associated with the effects of ECT observed in all patients. However, both ECT and clinical change were associated with RSFC modulation in dorsal ACC, mdTh and hippocampus, which may indicate that these regions underlie the mechanisms of clinical outcome in ECT and may be effective targets for future neurostimulation therapies.
Authors: Angela R Laird; P Mickle Fox; Simon B Eickhoff; Jessica A Turner; Kimberly L Ray; D Reese McKay; David C Glahn; Christian F Beckmann; Stephen M Smith; Peter T Fox Journal: J Cogn Neurosci Date: 2011-06-14 Impact factor: 3.225
Authors: H A Sackeim; J Prudic; D P Devanand; M S Nobler; S H Lisanby; S Peyser; L Fitzsimons; B J Moody; J Clark Journal: Arch Gen Psychiatry Date: 2000-05
Authors: Yvette I Sheline; Deanna M Barch; Joseph L Price; Melissa M Rundle; S Neil Vaishnavi; Abraham Z Snyder; Mark A Mintun; Suzhi Wang; Rebecca S Coalson; Marcus E Raichle Journal: Proc Natl Acad Sci U S A Date: 2009-01-26 Impact factor: 11.205
Authors: Jennifer S Perrin; Susanne Merz; Daniel M Bennett; James Currie; Douglas J Steele; Ian C Reid; Christian Schwarzbauer Journal: Proc Natl Acad Sci U S A Date: 2012-03-19 Impact factor: 11.205
Authors: Megha M Vasavada; Amber M Leaver; Stephanie Njau; Shantanu H Joshi; Linda Ercoli; Gerhard Hellemann; Katherine L Narr; Randall Espinoza Journal: J ECT Date: 2017-12 Impact factor: 3.635
Authors: Benjamin S C Wade; Jing Sui; Stephanie Njau; Amber M Leaver; Megha Vasvada; Boris A Gutman; Paul M Thompson; Randal Espinoza; Roger P Woods; Christopher C Abbott; Katherine L Narr; Shantanu H Joshi Journal: Proc IEEE Int Symp Biomed Imaging Date: 2017-06-19
Authors: Benjamin S C Wade; Gerhard Hellemann; Randall T Espinoza; Roger P Woods; Shantanu H Joshi; Ronny Redlich; Anders Jørgensen; Christopher C Abbott; Ketil J Oedegaard; Shawn M McClintock; Leif Oltedal; Katherine L Narr Journal: J ECT Date: 2020-06 Impact factor: 3.692
Authors: Amber M Leaver; Megha Vasavada; Shantanu H Joshi; Benjamin Wade; Roger P Woods; Randall Espinoza; Katherine L Narr Journal: Biol Psychiatry Date: 2018-10-05 Impact factor: 12.810
Authors: Jennifer L Kruse; Richard Olmstead; Gerhard Hellemann; Elizabeth C Breen; Susannah J Tye; John O Brooks; Benjamin Wade; Eliza Congdon; Randall Espinoza; Katherine L Narr; Michael R Irwin Journal: J Psychiatr Res Date: 2021-06-09 Impact factor: 5.250